设计一个响应对持续干预 (ROCI) 随机试验:在PARADIGM4TB试验的第2C阶段 (持续时间范围) 的实施
Tra My Pham1, Angela M Crook1, Katie Rolfe2
1MRC Clinical Trials Unit at UCL, London, UK.
Contemporary clinical trials
|July 11, 2025
概括
响应对持续干预 (ROCI) 试验设计提供了一种优化结核病 (TB) 治疗持续时间的实用方法. 模拟研究表明,ROCI试验可以有效地确定最佳治疗长度,改进标准方法.
科学领域:
- 临床试验的设计
- 药物指标 (Pharmacometrics) 是一个指标.
- 传染病流行病学 传染病流行病学
背景情况:
- 结核病 (TB) 治疗是漫长而复杂的,需要高效的试验设计.
- 标准的非劣势性试验通常用于评估较短的结核病治疗方案.
- 响应对持续干预 (ROCI) 设计是一种用于优化持续治疗变量 (如持续时间) 的新方法.
研究的目的:
- 证明模拟在设计结核病ROCI试验中的实用性.
- 使用 PARADIGM4TB 2C 期试验作为 ROCI 设计模拟的案例研究.
- 为了优化新型结核病治疗的持续时间,与标准的6个月疗程相比.
主要方法:
- 使用模拟建模来设计用于优化结核病治疗的ROCI试验.
- PARADIGM4TB 2C期试验的持续时间组成部分作为一个案例研究.
- 用分数多项式建模 (一级) 来分析持续时间-响应关系.
主要成果:
- 一个200名患者的ROCI设计 (5个新疗法臂,40个标准护理) 提供了足够的功率来确定最佳的结核病治疗持续时间.
- 分数多项式建模提高了与对对比较相比选择更短的持续时间的功率.
- 5个持续时间的ROCI设计在持续时间-响应曲线不平坦时,比3个持续时间的设计表现出更好的操作特性.
结论:
- ROCI试验设计是优化结核病治疗方案的一个有希望的选择.
- 模拟研究对于有效设计ROCI试验和探索关键考虑因素至关重要.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
613
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
13.7K
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.6K
Study Designs in Epidemiology
422
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
422
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Randomized Experiments
7.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
178
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
178
